Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans
about
Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical ImplicationsEarly Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies.Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis.A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans.Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis.The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers.Molecular Genetics and New Medication Strategies for Opioid AddictionUp-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cellsEmerging Evidence for Cannabis' Role in Opioid Use Disorder
P2860
Q26747507-BB07E854-EA0D-40C6-AD66-E3C9D3899499Q27336497-99D932D1-AE48-4C71-A154-5E0FB45ADD99Q38598487-DF28DEE1-1F7F-4EAC-9CD0-7E50A470D39BQ38842132-FC2FE942-BB91-4E62-8995-D28782ED8A50Q41016981-294B5268-4DD3-4B5F-9CDF-DAC8B9AD5AF8Q41560648-62655285-0C3E-4665-830D-7F5B512CC07DQ47378591-6582D933-3917-4769-AAE7-98CD1DBC191FQ47643955-845DC2F7-7E1C-4FF7-BB7D-4AE1805289C6Q50048038-BBBCCE6E-689F-4D73-BC9E-603168CE13B2Q52861250-D7BBA9DB-3705-43CE-8D10-5A48B62EDB61Q55011490-870A3C72-6581-4FC7-953F-2E2881D69C6EQ57133609-12453D5D-3253-4D30-8AC9-5E41423650FEQ57818333-365C0663-E0C0-48E0-84B8-2BF683C9A93AQ58775143-16CF4BAD-68B2-401D-BAD8-522E58F7F309
P2860
Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@ast
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@en
type
label
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@ast
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@en
prefLabel
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@ast
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@en
P2093
P2860
P921
P1476
Safety and pharmacokinetics of ...... intravenous fentanyl in humans
@en
P2093
Alex F Manini
Allan J Barnes
Didier Jutras-Aswad
Gary Winkel
Georgia Yiannoulos
Mateus M Bergamaschi
Rajita Sinha
Ruben Olmedo
Stephanie Hernandez
P2860
P304
P356
10.1097/ADM.0000000000000118
P577
2015-05-01T00:00:00Z